Mundipharma Gains License to Market and Distribute GUARDIX-SG (TM) in Southeast Asia
SINGAPORE, June 6, 2018 /PRNewswire/ — Mundipharma has announced a licensing agreement with Korean biomedical firm, Genewel Co.Ltd, to market and distribute its GUARDIX-SG™ Surgical Adhesion Barrier portfolio across Southeast Asia. GUARDIX-SG™ is used in surgery as a biodegradable mechanical barrier, reducing abnormal internal scarring post surgery by separating the internal tissues and organs while they heal. …